Passa al contenuto
Merck
Tutte le immagini(1)

Documenti

890898P

Avanti

DOTMA

Avanti Research™ - A Croda Brand

Sinonimo/i:

1,2-di-O-octadecenyl-3-trimethylammonium propane (chloride salt)

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula empirica (notazione di Hill):
C42H84ClNO2
Numero CAS:
104872-42-6
Peso molecolare:
670.57
Codice UNSPSC:
12352211
NACRES:
NA.25

Forma fisica

powder

Confezionamento

pkg of 2 × 100 mg (890898P-200mg)
pkg of 1 × 25 mg (890898P-25mg)

Produttore/marchio commerciale

Avanti Research™ - A Croda Brand

applicazioni

advanced drug delivery

Tipo di lipide

cationic lipids
transfection

Condizioni di spedizione

dry ice

Temperatura di conservazione

−20°C

Stringa SMILE

[H]C(C[N+](C)(C)C)(OCCCCCCCC/C=C\CCCCCCCC)COCCCCCCCC/C=C\CCCCCCCC.[Cl-]

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Categorie correlate

Applicazioni

DOTMA is suitable for use as a building block of miRNA delivery system and in the preparation.

Azioni biochim/fisiol

DOTMA is a cationic lipid, used as a non-viral vector for gene therapy. It exhibits effective in vitro and in vivo gene transfection. DOTMA induces a positive charge on the liposomes and thus promotes efficient liposome - cell membrane interaction.

Confezionamento

5 mL Clear Glass Sealed Ampule (890898P-200mg)
5 mL Clear Glass Sealed Ampule (890898P-25mg)

Note legali

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Codice della classe di stoccaggio

11 - Combustible Solids

Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 10

1 of 10

18:1 TAP (DOTAP) Avanti Research™ - A Croda Brand

Avanti

890890C

18:1 TAP (DOTAP)

1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine ≥99.0% (10 mg phospholipid per ml CHCl3, TLC)

Sigma-Aldrich

42490

1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine

DC-Cholesterol HCl Avanti Research™ - A Croda Brand 700001P, powder

Avanti

700001P

DC-Cholesterol HCl

3-(Dimethylamino)-1,2-propanediol 98%

Sigma-Aldrich

210218

3-(Dimethylamino)-1,2-propanediol

GL67 Avanti Research™ - A Croda Brand

Avanti

890893P

GL67

18:0 DDAB Avanti Research™ - A Croda Brand

Avanti

890810P

18:0 DDAB

L-α-Phosphatidylethanolamine, dioleoyl ≥99% (GC), ≥98% (TLC), lyophilized powder

Sigma-Aldrich

P1223

L-α-Phosphatidylethanolamine, dioleoyl

18:1 DAP Avanti Research™ - A Croda Brand 890850C

Avanti

890850C

18:1 DAP

1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine ≥97.0% (TLC)

Sigma-Aldrich

76548

1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine

DMG-PEG 2000 Avanti Research™ - A Croda Brand

Avanti

880151P

DMG-PEG 2000

Yun Wu et al.
Molecular therapy. Nucleic acids, 2, e84-e84 (2013-04-18)
MicroRNA-29b (miR-29b) expression has been shown to be reduced in non-small-cell lung cancer (NSCLC) tissues. Here, we have identified the oncogene cyclin-dependent protein kinase 6 (CDK6) as a direct target of miR-29b in lung cancer. We hypothesized that in vivo
The use of cationic microbubbles to improve ultrasound-targeted gene delivery to the ischemic myocardium
Sun L, et al.
Biomaterials, 34(8), 2107-2116 (2013)
Jinhong Meng et al.
Scientific reports, 10(1), 1046-1046 (2020-01-25)
P53 mutations are responsible for drug-resistance of tumour cells which impacts on the efficacy of treatment. Alternative tumour suppressor pathways need to be explored to treat p53- deficient tumours. The E3 ubiquitin ligase, ITCH, negatively regulates the tumour suppressor protein
Jayesh A Kulkarni et al.
ACS nano, 12(5), 4787-4795 (2018-04-04)
Lipid nanoparticles (LNPs) containing short interfering RNA (LNP-siRNA) and optimized ionizable cationic lipids are now clinically validated systems for silencing disease-causing genes in hepatocytes following intravenous administration. However, the mechanism of formation and certain structural features of LNP-siRNA remain obscure.

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.